US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 4.9200
- +0.0700+1.44%
Close Nov 22 16:00 ET
16.77MMarket Cap-377P/E (TTM)
4.9300High4.6800Low56.02KVolume4.8800Open4.8500Pre Close269.35KTurnover2.12%Turnover RatioLossP/E (Static)3.41MShares29.400052wk High0.17P/B13.00MFloat Cap2.770052wk Low--Dividend TTM2.64MShs Float21599978.4000Historical High--Div YieldTTM5.16%Amplitude2.7700Historical Low4.8080Avg Price1Lot Size
Tenax Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -48.35%-3.09M | -228.41%-3.03M | -199.48%-5.17M | 48.16%-5.9M | 30.45%-1.17M | 37.52%-2.08M | 73.10%-922.97K | 41.28%-1.72M | -4.90%-11.39M | 39.00%-1.69M |
| Net income from continuing operations | -100.84%-3.96M | -223.20%-3.58M | -170.04%-3.8M | 30.21%-7.71M | -26.55%-3.23M | 32.39%-1.97M | 61.33%-1.11M | 48.31%-1.41M | 65.98%-11.05M | 20.61%-2.55M |
| Operating gains losses | -60.59%14.59K | -53.69%22.06K | 68.94%118.79K | -47.03%191.98K | -55.26%37.01K | -57.25%37.01K | -56.71%47.64K | -15.35%70.31K | -31.17%362.41K | -61.80%82.73K |
| Depreciation and amortization | --0 | --0 | --0 | -93.32%7.57K | -83.88%4.71K | -96.60%969 | -96.43%1K | -96.76%895 | 3.99%113.33K | 8.84%29.2K |
| Other non cash items | -23.44%6.31K | 8.59%9.19K | 79.23%7.96K | 439.43%23.97K | --2.82K | 2,116.40%8.25K | 470.28%8.46K | 71.74%4.44K | -99.98%4.44K | --0 |
| Change In working capital | 648.42%852.27K | 306.53%513.33K | -279.29%-1.49M | 292.92%1.58M | 168.22%2.01M | 70.67%-155.4K | 117.79%126.27K | -19.54%-393.76K | -34.55%-820.86K | 276.51%748.09K |
| -Change in receivables | -148.86%-240.93K | 230.93%677.89K | -107.79%-18.29K | 14.26%-305.69K | -359.37%-648.53K | -158.75%-96.82K | 171.41%204.85K | 148.46%234.8K | -1,484.53%-356.52K | 101.52%250.04K |
| -Change in payables and accrued expense | 1,965.88%1.09M | -109.43%-164.56K | -134.69%-1.48M | 647.71%1.89M | 401.71%2.66M | 91.18%-58.59K | 80.04%-78.58K | -442.26%-628.57K | 36.66%-344.95K | 430.68%529.21K |
| -Change in other current liabilities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -177.66%-119.39K | -24.08%-31.15K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -48.35%-3.09M | -228.41%-3.03M | -199.48%-5.17M | 48.16%-5.9M | 30.45%-1.17M | 37.52%-2.08M | 73.10%-922.97K | 41.28%-1.72M | -4.90%-11.39M | 39.00%-1.69M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 222.38%2.84K | 0 | 0 | 1.6K | 119.63%1.24K | -100.51%-2.32K | 335.57%4K |
| Net PPE purchase and sale | --0 | --0 | --0 | 222.38%2.84K | --0 | --0 | --1.6K | 119.63%1.24K | 55.77%-2.32K | 335.57%4K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 222.38%2.84K | --0 | --0 | --1.6K | 119.63%1.24K | -100.51%-2.32K | 335.57%4K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 53,820.57%92.01M | -34.50%-134.37K | -43.47%7.92M | 71.10%13.57M | -8,556.91%-174.47K | -86.43%-171.28K | -101.28%-99.91K | 6,026.36%14.01M | -18.55%7.93M | 2.06K |
| Net issuance payments of debt | -62.77%-278.8K | 20.09%-134.37K | 20.53%-87.73K | ---624.3K | ---174.47K | -86.43%-171.28K | -22.84%-168.16K | -148.26%-110.4K | --0 | --0 |
| Net common stock issuance | 32,632.55%91.95M | --0 | -53.05%6.52M | ---- | ---- | ---282.65K | -99.14%68.25K | --13.9M | ---- | ---- |
| Proceeds from stock option exercised by employees | --97 | --0 | 257.32%1.83M | 78.97%14.19M | --13.68M | --0 | --0 | --511.31K | -18.55%7.93M | ---- |
| Net other financing activities | ---- | --0 | -20.52%-340.64K | ---- | ---- | ---- | --0 | ---282.65K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 53,820.57%92.01M | -34.50%-134.37K | -43.47%7.92M | 71.10%13.57M | -8,556.91%-174.47K | -86.43%-171.28K | -101.28%-99.91K | 6,026.36%14.01M | -18.55%7.93M | --2.06K |
| Net cash flow | ||||||||||
| Beginning cash position | -29.94%9.38M | -12.94%12.55M | 361.09%9.79M | -61.97%2.12M | 192.69%11.14M | 85.27%13.39M | 402.49%14.41M | -61.97%2.12M | -10.66%5.58M | -54.44%3.81M |
| Current changes in cash | 4,048.03%88.93M | -209.95%-3.17M | -77.57%2.76M | 321.62%7.67M | 19.83%-1.35M | 34.19%-2.25M | -123.42%-1.02M | 552.67%12.29M | -419.31%-3.46M | 39.26%-1.68M |
| End cash Position | 782.41%98.31M | -29.94%9.38M | -12.94%12.55M | 361.09%9.79M | 361.09%9.79M | 192.69%11.14M | 85.27%13.39M | 402.49%14.41M | -61.97%2.12M | -61.97%2.12M |
| Free cash flow | -48.35%-3.09M | -228.41%-3.03M | -199.48%-5.17M | 48.17%-5.9M | 30.29%-1.17M | 37.52%-2.08M | 73.10%-922.97K | 41.41%-1.72M | -4.87%-11.39M | 39.18%-1.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data